IVF with Endometriosis: Protocols, Surgery Debate, Success Rates

Published: May 2026 · 13 min read

I–IV

ASRM disease stages

3–6 mo

Long agonist downreg

Freeze-all

Often preferred

3+ transfers

RIF threshold

Endometriosis is the second-most-common diagnosis among IVF patients after PCOS, and one of the most variable in how it affects outcomes. Mild disease often does not move the needle; severe disease can require careful protocol design, surgical decisions, and consideration of adjuvant therapies. This guide walks through what actually changes, what is debatable, and what to ask before committing to a protocol.

Is IVF more difficult with endometriosis?

It depends on disease severity. Stage I–II (mild-to-minimal) endometriosis usually has minimal impact on IVF outcomes. Stage III–IV (moderate-to-severe), particularly with endometriomas or deep infiltrating disease, can reduce ovarian reserve, complicate egg retrieval, and reduce implantation. With appropriate protocol selection — often a long agonist protocol with freeze-all and FET — cumulative success rates approach those of non-endometriosis patients.

Does endometriosis surgery help before IVF?

Sometimes — and sometimes it makes things worse. For mild disease without endometriomas, surgery rarely improves IVF outcomes and may damage ovarian reserve. For severe pain or quality-of-life reasons, surgery may be justified independent of IVF. For endometriomas, removal is rarely required for IVF success and can reduce AMH; large or symptomatic endometriomas are evaluated case-by-case. Decisions should be made jointly by a reproductive endocrinologist and a fertility-specialist endometriosis surgeon.

Endometriosis Stages and Their Impact on IVF

StageDescriptionTypical IVF impact
Stage I (minimal)Few superficial implantsMinimal
Stage II (mild)More implants, mild adhesionsMinimal to small
Stage III (moderate)Endometriomas, more adhesionsModerate — possible AMH reduction, retrieval complexity
Stage IV (severe)Large endometriomas, dense adhesions, deep infiltrating diseaseSignificant — protocol changes, sometimes surgery, often FET preferred

Worth noting: ASRM staging reflects anatomical disease burden, not necessarily IVF outcome. Stage I disease can still cause significant inflammation and implantation issues; stage IV with quiescent disease can do unexpectedly well.

Should You Have Surgery First?

This is one of the most contested decisions in fertility medicine, and it deserves a careful conversation rather than a default answer.

Cases where surgery often helps

  • • Severe pelvic pain unresponsive to medical management
  • • Deep infiltrating endometriosis with bowel or bladder involvement
  • • Hydrosalpinges (fluid-filled tubes) — well-evidenced to reduce IVF success unless removed
  • • Very large symptomatic endometriomas (typically over 4–5 cm)

Cases where surgery may make things worse

  • • Mild disease with no symptoms — no IVF benefit, possible reserve loss
  • • Older patients where time is limited — delay rarely justified
  • • Asymptomatic endometriomas in patients with low AMH
  • • Repeat surgery on previously operated endometriomas — particularly damaging to reserve

A useful frame

Surgery for symptoms is medically justified on its own. Surgery purely to improve IVF outcome should clear a high bar — and is rarely the right answer for mild disease.

Your IVF journey, organised and free

IVFPath is built for IVF patients — track medications, appointments, lab results, and costs all in one place.

💊

Medication Reminders

Never miss a dose — log every injection and tablet

📅

Appointment Calendar

All your scans, retrievals and transfers in one view

💰

Cost Tracker

Track spending so nothing is a surprise

Start for free — no card needed

Free · No credit card · Works on any device

IVF Protocol Options

Long GnRH agonist (ultra-long) protocol

Pre-IVF GnRH agonist (Lupron / Decapeptyl / Zoladex) for 3–6 months to suppress endometriosis activity, followed by stimulation. Supported by ESHRE guidance and meta-analyses for moderate-to-severe disease. Trade-off: 3–6 month delay and side effects of medical menopause.

Standard long agonist protocol

Agonist downregulation from luteal phase, followed by stimulation. Less aggressive suppression than ultra-long. Often used for moderate disease where time is constrained.

Antagonist protocol

Standard antagonist used for mild disease, low AMH (where pre-suppression risks further reserve loss), or older patients. Common default when endometriosis is mild and reserve is already compromised.

Mini-IVF / mild stimulation

Sometimes used for severe endometriosis with very low AMH where conventional doses produce poor responses anyway. Lower medication burden, sometimes equivalent egg yield in this specific patient group.

Endometriomas and Egg Retrieval

Endometriomas (ovarian cysts containing old menstrual blood, also called "chocolate cysts") complicate retrieval but rarely prevent it.

  • Most retrievals are performed safely around endometriomas; needle path is planned to avoid them
  • Endometrioma rupture during retrieval is uncommon and usually managed without complication
  • Antibiotic prophylaxis is sometimes given for retrievals in patients with endometriomas
  • Bilateral large endometriomas may reduce accessible follicles, lowering yield

Cystectomy is not free

Removing endometriomas surgically reduces AMH on average — sometimes substantially. Repeat surgery is particularly damaging. For most asymptomatic patients with endometriomas, preserving the cyst and proceeding with IVF is the better option, except where size, symptoms, or accessibility issues clearly justify removal.

Why Freeze-All Is Often Used

For moderate-to-severe endometriosis, many clinics now default to freeze-all + later FET. The reasoning:

  • Endometrium under fresh stim conditions is often suboptimal in endometriosis
  • Premature progesterone rise is more common, particularly with long agonist protocols
  • FET allows controlled endometrial preparation, sometimes with extended progesterone exposure
  • Some clinics combine FET with brief pre-transfer GnRH agonist suppression

Recurrent Implantation Failure

Endometriosis is overrepresented in RIF cohorts. After 2–3 failed transfers of good-quality embryos, additional workup is reasonable:

  • Hysteroscopy to rule out polyps, fibroids, scar tissue, or chronic endometritis
  • ERA (endometrial receptivity test) to check timing of implantation window
  • Endometrial biopsy for chronic endometritis with appropriate antibiotic treatment if positive
  • Immune workup at experienced centres (NK cells, autoimmune panel)
  • PGT-A if not already done, to ensure transferred embryos are euploid

Comparing protocols across two clinics?

Endometriosis IVF involves more protocol variation than most diagnoses. If you have second opinions from different clinics and want a plain-English comparison of what each is proposing — and why one might suit your stage better — Nestie's AI assistant can help you work through the choices.

Compare protocols with Nestie →

Questions to Ask Your Clinic

  • What stage do you assess my endometriosis at, and based on what evidence?
  • Are you recommending long agonist downregulation? For how long?
  • Would you recommend laparoscopy before IVF, and if so, why specifically?
  • How are you planning to manage my endometrioma during retrieval?
  • Are you defaulting to freeze-all? Under what conditions?
  • If implantation fails, what is your next-step workup?
  • What is your live birth rate per transfer for endometriosis patients in my age group?

Frequently Asked Questions

References

Guidance based on ESHRE endometriosis guidelines, ASRM practice committee opinions, and published meta-analyses on long agonist protocols and surgical management before IVF. Endometriosis treatment is highly individualised — protocols and decisions should be made with a clinician familiar with your full history.